Launching DTC models requires navigating regulatory and licensing rules.
Spreeha Choudhury, JD, PharmD
Advertisement
Articles by Spreeha Choudhury, JD, PharmD
The idea of denying people proven medicines in the name of research has a dark legacy in this country.
Advertisement
Latest Updated Articles
Navigating Pharmacy Models and Regulatory Pitfalls When Launching Direct-To-Consumer ProgramsPublished: October 10th 2025 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Novartis Planning Layoffs for 550 Positions at Switzerland Facility
2
How Technology is Moving the Industry Away from Animal Testing: Q&A with Dr. Jo Varshney
3
Novo Nordisk’s Stock Reacts to Unsuccessful Phase III Trial Results
4
What Does the List of Approved Drugs Reveal About FDA's Priority Review Voucher Program?
5
